|
|
| Informatique - Télécommunication > Etude de marché sectorielle |
| Europe IT Spending on Business Intelligence to 2012 Pharmaceutical Technology |
|
|
|
|
€ 1 036,00 |
Editeur
: |
Datamonitor |
Langue
: |
Anglais |
Date de publication : |
Avril 2007 |
Taille du document : |
10 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
Documents Publics |
1,200,000
documents |
Téléchargement illimités |
|
|
|
Etudes Privées |
50,000 rapports et études |
Paiement à la piéce |
|
|
|
|
| |
|
1.Télécharger nos rapports publics
Accés complet à plus de 1,2 Million de documents publics : études de marché, statistiques sectorielles, fiches pays, monographie d'entreprises, veille concurentielle, rapports annuels...
|
| Nos documents publics sur le même théme (3) |
|
|
|
| 72 pages | Mars 2002 | Anglais
|
|
|
| Main
focus: |
biotech,genomics,human genome,gene therapy,...,...
|
| Research
focus: |
market size and estimates,market outlook, |
| Geographic
focus: |
usa,japan,canada,united kingdom,mexico |
| |
|
|
|
|
| 271 pages | Juillet 2006 | Anglais
|
|
|
| Main
focus: |
biotechnology,biotech,biotech crops,bioinformatic,...,...
|
| Research
focus: |
competition analysis,market size and estimates, |
| Geographic
focus: |
france,united kingdom,hungary,czech republic,... |
| |
|
|
|
|
| 44 pages | Janvier 2001 | Anglais
|
|
|
| Main
focus: |
biotechnology,biotech,biotechnology patents,...,...
|
| Research
focus: |
market size and estimates,market definition, |
| Geographic
focus: |
usa,switzerland,united kingdom,germany,france |
| |
|
|
|
|
| Autres recherches sur le même thème |
|
|
|
| |
| |
|
| |
|
2.
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
IT Opportunities in State and Local Government
65 pages | Juillet 2005 |
IntroductionDriven by pressure to improve constituent services, reduce costs and develop efficiency, US state and local governments are increasing their technology spending.
Changes in internal str |
1 836,00 €
|
| |
| |
Global sourcing in European and North American FS
37 pages | Avril 2005 |
IntroductionThis report analyses the role of global sourcing strategies in European and North American financial services, highlighting the key trends and opportunities as well as the barriers that co |
1 836,00 €
|
| |
| |
ICT Opportunities in the European healthcare market
93 pages | Juillet 2005 |
IntroductionHealthcare providers are increasingly being faced with competing demands surrounding the delivery of treatment and care.
Clinicians and administrators are under pressure to cut costs an |
2 716,00 €
|
| |
| |
MarketWatch: Technology
58 pages | Janvier 2005 |
Datamonitor's Technology MarketWatch is a one-stop news shop for time-pressed executives.
It provides monthly insight into the key events in the technology industry.
The report contains the late |
160,00 €
|
| |
| |
ICT Opportunities in Healthcare: Key issues, growth prospects and market opportunities in Europe and the US
163 pages | Avril 2005 |
Healthcare has always been at the cutting edge of technology for patient treatments and monitoring, yet the industry has made little use of information and communications technologies (ICT) to support |
1 224,00 €
|
| |
| |
European Retail Banking Technology Spending Strategies: a survey of 100 decision-makers
66 pages | Janvier 2005 |
IntroductionThis report presents the views of 100 business and technology decision-makers in the retail banking sector, drilling down into IT strategy drivers and pinpointing key investment areas for |
2 716,00 €
|
| |
| |
MarketWatch: Technology
68 pages | Juin 2005 |
Datamonitor's Technology MarketWatch is a one-stop news shop for time-pressed executives.
It provides monthly insight into the key events in the technology industry.
The report contains the late |
160,00 €
|
| |
| |
Exploiting the SME opportunity
61 pages | Décembre 2004 |
IntroductionSmall and medium-sized enterprises (SMEs) are one of the fastest growing ICT opportunities, but are notoriously hard to target.
Evolving distribution and hosting models make SMEs more a |
2 716,00 €
|
| |
| |
Technology spending plans in UK local government
65 pages | Avril 2005 |
IntroductionThrough granular analysis of the technology spending plans of 100 councils, this end-user study offers insights into the networking, application, security and outsourcing opportunities in |
2 716,00 €
|
| |
| |
Annual Report on China's IT Industry, 2004-2005
160 pages | Août 2005 |
The report sums up the development and basic characteristics of the global and Chinese IT industries in 2004.
It analyzes the restructuring of China's information industry and development trend of |
1 784,50 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
| Europe IT Spending on Business Intelligence to 2012 Pharmaceutical Technology |
|
|
Introduction
Although BI in the earlier stages of drug development remains an emergent solution area in the pharmaceutical market, contextual forces such as pipeline productivity pressures and growing generic competition will drive increased spending on BI in the near future.
Scope
Identifies potential growth areas for technology in Big Pharma in Europe Quantifies spending on BI solutions by pharmaceutical end-user segments Segments IT spending by technology, country and end-user group
Highlights
The adoption of BI solutions will exhibit strong growth over the next five years. The Biotech segment will increase their spending on BI solutions more quickly than Big Pharma BI adoption by clinical end-user groups will demonstrate the most rapid growth compared to R&D, manufacturing and sales & marketing groups.
Reasons to Purchase
Understand the potential opportunity size for BI solutions in the pharmaceutical market. Identify the BI technology areas in which pharmaceutical companies will invest the most heavily. Recognize the differences in BI spending across segments of the market and end-user groups.
|
|
Introduction
Although BI in the earlier stages of drug development remains an emergent solution area in the pharmaceutical market, contextual forces such as pipeline productivity pressures and growing generic competition will drive increased spending on BI in the near future.
Scope
Identifies potential growth areas for technology in Big Pharma in Europe Quantifies spending on BI solutions by pharmaceutical end-user segments Segments IT spending by technology, country and end-user group
Highlights
The adoption of BI solutions will exhibit strong growth over the next five years. The Biotech segment will increase their spending on BI solutions more quickly than Big Pharma BI adoption by clinical end-user groups will demonstrate the most rapid growth compared to R&D, manufacturing and sales & marketing groups.
Reasons to Purchase
Understand the potential opportunity size for BI solutions in the pharmaceutical market. Identify the BI technology areas in which pharmaceutical companies will invest the most heavily. Recognize the differences in BI spending across segments of the market and end-user groups.
|
|
|
PPLSEN
|
|
|
|
|
